Suppr超能文献

取栓支架与其他急性脑卒中血管内治疗方法的比较:手术结果及其与预后的关系。

Stentrievers versus other endovascular treatment methods for acute stroke: comparison of procedural results and their relationship to outcomes.

机构信息

Stroke Unit, Department of Neurology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

出版信息

J Neurointerv Surg. 2014 May;6(4):265-9. doi: 10.1136/neurintsurg-2013-010748. Epub 2013 May 28.

Abstract

BACKGROUND AND PURPOSE

The use of stentrievers (ST) is rapidly growing due to several potential benefits over other available treatments. ST potentially restore flow before clot retrieval and reduce procedural time. We aimed to study the impact of these potential benefits.

METHODS

Patients with acute stroke treated with endovascular procedures in two stroke centers were studied. According to device availability, patients were treated either with intra-arterial tissue plasminogen activator (IAT), Merci or ST. We defined time to initial flow restoration as time from symptom onset to first pass of contrast to previously occluded arteries either through the deployed device or after recanalization. Complete recanalization (Thrombolysis In Cerebral Infarction >2b), day 5 National Institute of Health Stroke Scale (NIHSS) score and favorable outcome at 3 months (modified Rankin Scale score≤2) were recorded.

RESULTS

A total of 315 patients were studied: 127 IAT, 119 Merci, 69 ST (26 Trevo, 43 Solitaire). No major differences were observed in baseline characteristics between the treatment groups. The rate of complete recanalization was higher with ST (67.2%) than with IAT (50.8%) or Merci (57.3%) (p=0.05). Time from groin puncture to final recanalization was lower with ST (88±46 min) than with IAT (103±70 min) or Merci (128±62 min) (p<0.01) and time from groin puncture to initial flow restoration was shorter with ST (36±18 min) than with IAT (92±67 min) or Merci (114±57 min) (p<0.01). Discharge NIHSS was lower in the ST group (7, IQR 1-26) than in the IAT (14, 2-30) or Merci (12, 5-30) groups (p=0.05) and the rate of favorable outcome was higher: ST (52.9%) vs IAT (33.9%) and Merci (40%) (p=0.03). The use of a ST increased the odds of a favorable outcome (OR 1.9, 95% CI 1.04 to 3.39; p=0.037).

CONCLUSIONS

In acute endovascular treatment of stroke, the use of ST may increase recanalization and reduce time to flow restoration leading to improved outcomes.

摘要

背景与目的

由于支架取栓术(ST)具有优于其他可用治疗方法的多种潜在优势,其应用正在迅速增加。ST 可在血栓清除前恢复血流,同时缩短手术时间。本研究旨在探讨这些潜在优势的影响。

方法

在两家卒中中心接受血管内治疗的急性卒中患者参与了本研究。根据设备的可用性,患者分别接受了动脉内组织型纤溶酶原激活剂(IAT)、Merci 或 ST 治疗。我们将首次造影剂通过闭塞血管的时间定义为从发病到血流恢复的时间,通过已展开的器械或再通后。完全再通(血栓溶栓分级 >2b)、第 5 天国立卫生研究院卒中量表(NIHSS)评分和 3 个月时的良好结局(改良 Rankin 量表评分≤2)被记录下来。

结果

共纳入 315 例患者:127 例行 IAT,119 例行 Merci,69 例行 ST(26 例行 Trevo,43 例行 Solitaire)。各组间基线特征无显著差异。ST 组的完全再通率(67.2%)高于 IAT 组(50.8%)或 Merci 组(57.3%)(p=0.05)。ST 组从股动脉穿刺到最终再通的时间(88±46min)较 IAT 组(103±70min)或 Merci 组(128±62min)更短(p<0.01),从股动脉穿刺到首次血流恢复的时间(36±18min)也较 IAT 组(92±67min)或 Merci 组(114±57min)更短(p<0.01)。ST 组出院时 NIHSS 评分(7,IQR 1-26)低于 IAT 组(14,2-30)或 Merci 组(12,5-30)(p=0.05),良好结局率更高:ST 组(52.9%)优于 IAT 组(33.9%)和 Merci 组(40%)(p=0.03)。使用 ST 可增加良好结局的几率:OR 1.9,95% CI 1.04-3.39;p=0.037)。

结论

在急性血管内卒中治疗中,ST 的应用可能增加再通率并缩短血流恢复时间,从而改善预后。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验